Previous study showed that the effect of CysC on modulating the prostate cancer cell invasion was provoked by crosstalk between cystatin C and AR-mediated pathways and Erk2 inhibitor that specifically inhibited MAPK/Erk2 activity44. The gene discussed is MAPK1; the disease is prostate carcinoma.